Cilta-cel OOS Therapy clinical trials

Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma

This program offers a special cell therapy called cilta-cel to people with a type of blood cancer called multiple myeloma. It's for patients who can't get this treatment elsewhere and for whom regular cilta-cel or other treatments aren't suitable.